Authors: Ertel, EA Campbell, KP Harpold, MM Hofmann, F Mori, Y Perez-Reyes, E Schwartz, A Snutch, TP Tanabe, T Birnbaumer, L Tsien, RW Catterall, WA

Citation: Ea. Ertel et al., Nomenclature of voltage-gated calcium channels, NEURON, 25(3), 2000, pp. 533-535

Authors: Perchenet, L Bernardeau, A Ertel, EA

Citation: L. Perchenet et al., Pharmacological properties of Ca(v)3.2, a low voltage-activated Ca2+ channel cloned from human heart, N-S ARCH PH, 361(6), 2000, pp. 590-599

Authors: Benardeau, A Weissenburger, J Hondeghem, L Ertel, EA

Citation: A. Benardeau et al., Effects of the T-type Ca2+ channel blocker mibefradil on repolarization ofguinea pig, rabbit, dog, monkey, and human cardiac tissue, J PHARM EXP, 292(2), 2000, pp. 561-575

Authors: Smith, MM Warren, VA Thomas, BS Brochu, RM Ertel, EA Rohrer, S Schaeffer, J Schmatz, D Petuch, BR Tang, YS Meinke, PT Kaczorowski, GJ Cohen, CJ

Citation: Mm. Smith et al., Nodulisporic acid opens insect glutamate-gated chloride channels: Identification of a new high affinity modulator, BIOCHEM, 39(18), 2000, pp. 5543-5554

Authors: Clozel, JP Ertel, EA Ertel, SI

Citation: Jp. Clozel et al., Voltage-gated T-type Ca2+ channels and heart failure, P ASS AM PH, 111(5), 1999, pp. 429-437

Authors: Rossier, MF Ertel, EA Vallotton, MB Capponi, AM

Citation: Mf. Rossier et al., Inhibitory action of mibefradil on calcium signaling and aldosterone synthesis in bovine adrenal glomerulosa cells, J PHARM EXP, 287(3), 1998, pp. 824-831